Attention
Share
Ovarian cancer, breast cancer FDA approved authoritative certification, Laos Daxiong Pharmaceutical Olaparib/Olaparib 150mg 56 tablets
Price GH￠ 2,636.00
Coupons
More>
Comprehensive Score
5
cumulative comments 0Goods Guarantee 100% authenticity guarantee
Delivery address China
Ship to
FBM products: 7 days without reason return or exchange
False a compensate ten
Sperification
Quantity
Inventory 100
TospinoMall Commitment
TospinoMall guarantees the security of your transaction: we will only allocate funds to the seller after the buyer confirms the receipt of the goods!
Special recommendation
Afrilinker
Enter Store
Favorite Stores
Hot Picks of the Store
Ovarian cancer, breast cancer FDA approved authoritative certification, Laos Daxiong Pharmaceutical Olaparib/Olaparib 150mg 56 tablets
Indications: For: Ovarian cancer For maintenance treatment of adult patients with advanced epithelial ovarian cancer with deleterious or suspected deleterious germline or somatic BRCA mutations, For maintenance treatment of adult patients with recurrent epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, For treatment of adult patients with advanced ovarian cancer with deleterious or suspected deleterious germline BRCA mutations (gBRCAm), who have previously received three or more chemotherapy. Breast cancer. For treatment of adult patients with deleterious or suspected deleterious gBRCAm, HER2-positive metastatic breast cancer, who have received chemotherapy in the neoadjuvant, adjuvant, or metastatic setting. Pancreatic cancer is used for maintenance treatment of adult patients with harmful or suspected harmful gBRCAm metastatic prostate cancer. It is used to treat adult patients with metastatic castration-resistant prostate cancer (mCRPC) with harmful or suspected harmful germline or somatic homologous recombination repair (HRR) gene mutations.
Indications:
150mg*56 tablets/box
It is suitable for maintenance treatment of adult patients with platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after complete remission or partial remission of platinum-containing chemotherapy.
Recommended dose: {For reference only, follow the doctor's advice}
1. Orally twice a day, 300 mg each time. 2. Patients should start treatment with this product within 8 weeks after the end of platinum-containing chemotherapy and continue treatment until disease progression or unacceptable toxic reactions occur. 3. Swallow the whole tablet without chewing it. It can be used with meals and on an empty stomach.
